Gene · 3398
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis. | J Oncol | 2022 | 35401749 | PubTator, text mining | PubMed |
| Proteomic and Single-Cell Transcriptomic Dissection of Human Plasmacytoid Dendritic Cell Response to Influenza Virus. | Front Immunol | 2022 | 35401570 | PubTator, text mining | PubMed |
| Mammalian tumor-like organs. 2. Mammalian adipose has many tumor features and obesity is a tumor-like process. | Infect Agent Cancer | 2022 | 35395810 | PubTator, text mining | PubMed |
| Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches. | PLoS One | 2022 | 35390032 | PubTator, text mining | PubMed |
| Templated Insertions Are Associated Specifically with BRCA2 Deficiency and Overall Survival in Advanced Ovarian Cancer. | Mol Cancer Res | 2022 | 35385581 | PubTator, text mining | PubMed |
| Targeting transforming growth factor-β signalling for cancer prevention and intervention: Recent advances in developing small molecules of natural origin. | Clin Transl Med | 2022 | 35384373 | PubTator, text mining | PubMed |
| Differential regulation of transcription factor T-bet induction during NK cell development and T helper-1 cell differentiation. | Immunity | 2022 | 35381213 | PubTator, text mining | PubMed |
| PRMT5 Interacting Partners and Substrates in Oligodendrocyte Lineage Cells. | Front Cell Neurosci | 2022 | 35370564 | PubTator, text mining | PubMed |
| Single base substitution and insertion/deletion mutational signatures in adult core binding factor acute myeloid leukemia. | Leukemia | 2022 | 35365774 | PubTator, text mining | PubMed |
| Tissue-Dependent Adaptations and Functions of Innate Lymphoid Cells. | Front Immunol | 2022 | 35359972 | PubTator, text mining | PubMed |
| Transcriptomics Reveals the Mevalonate and Cholesterol Pathways Blocking as Part of the Bacterial Cyclodipeptides Cytotoxic Effects in HeLa Cells of Human Cervix Adenocarcinoma. | Front Oncol | 2022 | 35359411 | PubTator, text mining | PubMed |
| Heterogeneity of type 2 innate lymphoid cells. | Nat Rev Immunol | 2022 | 35354980 | PubTator, text mining | PubMed |
| The Opportunity of Proteomics to Advance the Understanding of Intra- and Extracellular Regulation of Malignant Hematopoiesis. | Front Cell Dev Biol | 2022 | 35350382 | PubTator, text mining | PubMed |
| Evaluation of Early Biomarkers of Atherosclerosis Associated with Polychlorinated Biphenyl Exposure: An in Vitro and in Vivo Study. | Environ Health Perspect | 2022 | 35349355 | PubTator, text mining | PubMed |
| Oocyte maturation abnormalities - A systematic review of the evidence and mechanisms in a rare but difficult to manage fertility pheneomina. | Turk J Obstet Gynecol | 2022 | 35343221 | PubTator, text mining | PubMed |
| Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression. | Oncoimmunology | 2022 | 35340661 | PubTator, text mining | PubMed |
| Human induced-T-to-natural killer cells have potent anti-tumour activities. | Biomark Res | 2022 | 35331335 | PubTator, text mining | PubMed |
| Epigenetic remodelling in human hepatocellular carcinoma. | J Exp Clin Cancer Res | 2022 | 35331312 | PubTator, text mining | PubMed |
| Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy. | J Pers Med | 2022 | 35330396 | PubTator, text mining | PubMed |
| Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment. | Int J Mol Sci | 2022 | 35328738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3398/papers?page=42